[
    [
        {
            "time": "2018-07-21",
            "original_text": "恒瑞医药需重新估值 创新药子板块将上演“戴维斯双击”——专访雷球资产投资总监顾斌",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "重新估值",
                    "创新药",
                    "戴维斯双击"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药需重新估值 创新药子板块将上演“戴维斯双击”——专访雷球资产投资总监顾斌",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-21",
            "original_text": "长生生物因“疫苗门”连续5日跌停，医药生物行业如何避雷？",
            "features": {
                "keywords": [
                    "长生生物",
                    "疫苗门",
                    "跌停",
                    "避雷"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "长生生物因“疫苗门”连续5日跌停，医药生物行业如何避雷？",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-20",
            "original_text": "复星医药(02196)子公司实体瘤治疗新药获准进行临床试验",
            "features": {
                "keywords": [
                    "复星医药",
                    "实体瘤",
                    "新药",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196)子公司实体瘤治疗新药获准进行临床试验",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-20",
            "original_text": "今日（7月20日）复星医药（600196）股票行情观点：等待趋势反转",
            "features": {
                "keywords": [
                    "复星医药",
                    "股票行情",
                    "趋势反转"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "今日（7月20日）复星医药（600196）股票行情观点：等待趋势反转",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-21",
            "original_text": "【国泰君安国际策略速评】医药行业：复星医药（2196.HK）配售6800万股H股集资25.8亿港元，不属于意外事件主要用于海外还债",
            "features": {
                "keywords": [
                    "复星医药",
                    "配售",
                    "集资",
                    "海外还债"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【国泰君安国际策略速评】医药行业：复星医药（2196.HK）配售6800万股H股集资25.8亿港元，不属于意外事件主要用于海外还债",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-21",
            "original_text": "46股获券商买入评级 正泰电器目标涨幅达56.32%",
            "features": {
                "keywords": [
                    "券商买入评级",
                    "正泰电器",
                    "目标涨幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电气设备"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "46股获券商买入评级 正泰电器目标涨幅达56.32%",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]